CN1899528B - Chinese patented medicine for treating psoriasis - Google Patents

Chinese patented medicine for treating psoriasis Download PDF

Info

Publication number
CN1899528B
CN1899528B CN2005100429520A CN200510042952A CN1899528B CN 1899528 B CN1899528 B CN 1899528B CN 2005100429520 A CN2005100429520 A CN 2005100429520A CN 200510042952 A CN200510042952 A CN 200510042952A CN 1899528 B CN1899528 B CN 1899528B
Authority
CN
China
Prior art keywords
radix
medicine
chinese patent
treatment
patent medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2005100429520A
Other languages
Chinese (zh)
Other versions
CN1899528A (en
Inventor
乔贞民
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2005100429520A priority Critical patent/CN1899528B/en
Publication of CN1899528A publication Critical patent/CN1899528A/en
Application granted granted Critical
Publication of CN1899528B publication Critical patent/CN1899528B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The Chinese medicine for treating psoriasis is prepared with white stiff silkworm, black snake, scorpion, gastrodia tuber, cassia twig and other Chinese medicinal materials. It possesses the functions of dredging the meridian passage, relieving liver qi, dispelling wind and dampness, stopping itching, cooling blood, promoting blood circulation and expelling toxin, and has obvious curative effect on psoriasis, taking convenience and no toxic side effect.

Description

The psoriatic Chinese patent medicine of a kind of treatment
Technical field
Content of the present invention belongs to the preparing technical field of pharmaceuticals, and relating to a kind of is psoriatic Chinese patent medicine of being used for the treatment of of feedstock production with the Chinese herbal medicine.
Background technology
Psoriasis also claims psoriasis, is commonly called as psoriasis, is a kind of chronic dermatosis of common easy recurrence.Great majority on sale in the market are used for the treatment of psoriatic medicine, as vaseline, boric acid ointment, dexamethasone ointment, methotrexate, cyclophosphamide etc., curative effect is very unobvious, and the toxic and side effects that has is very big, furthermore great majority all need be avioded certain food, and use very inconvenient.Because lack specific medicine, psoriasis is called as " not dead cancer ", belong to one of difficult problem of world medical circle tackling key problem, so be that those skilled in the art show great attention to and problem demanding prompt solution for a long time always.
Summary of the invention
The objective of the invention is at the existing problem of state of the art, by excavating the abundant Chinese medicine resource of motherland, so a kind of prescription science, preparation and taking convenience be provided, need not to aviod certain food, curative effect height, instant effect and be used for the treatment of psoriatic Chinese patent medicine preparation to what human body had no side effect.
To be the designer sum up development and obtain according to clinical practice for many years and taking in concurrently on a large amount of at all times pharmacy theories and the proved recipe basis by concentrated the preparation scheme of medicine of the present invention, it determination of treatment based on pathogenesis obtained through differentiation of symptoms and signs, treatment must aim at the pathogenesis of disease in principle according to the psoriatic etiology and pathology side of establishing, selected Bombyx Batryticatus, Zaocys, Squama Manis, Scorpio, Rhizoma Gastrodiae, Scolopendra, Ramulus Cinnamomi, Radix Angelicae Sinensis, Radix Bupleuri, river Niu Xi, Caulis Bambusae In Taenia, Fructus Chaenomelis, Radix Paeoniae Rubra, Cortex Moutan, Herba Schizonepetae, Radix Saposhnikoviae, Pericarpium Citri Reticulatae, Radix Glycyrrhizae totally ten eight flavor herbal raw materials are formed, and are effective Chinese medicine preparation.
The percentage by weight constituent content that constitutes psoriatic each medicine material of this treatment is:
Bombyx Batryticatus 6%~10%; Zaocys 5%~9%;
Squama Manis 4%~8%; Scorpio 1.6%~3%;
Rhizoma Gastrodiae 4%~8%; Scolopendra 1.6%~3%;
Ramulus Cinnamomi 4%~8%; Radix Angelicae Sinensis 5%~9%;
Radix Bupleuri 3%~7%; River cattle sunset 5%~9%;
Caulis Bambusae In Taenia 3%~6%; Fructus Chaenomelis 5%~9%;
Radix Paeoniae Rubra 3%~7%; Cortex Moutan 3%~7%;
Herba Schizonepetae 5%~9%; Radix Saposhnikoviae 5%~9%;
Pericarpium Citri Reticulatae 2%~4%; Radix Glycyrrhizae 6%~10%.
Pharmaceutical preparation of the present invention can be obtained by following preparation process: it is qualified earlier 18 flavor raw material of Chinese medicine such as Bombyx Batryticatus to be concocted, and weighing is complete, pulverizes, and method for making is made the honeyed pill that every ball contains crude drug in whole 4.5 grams routinely then, after sterilization back packed products.
In pharmaceutical preparation of the present invention, Bombyx Batryticatus, Zaocys, Squama Manis, Scorpio, Scolopendra are the in love product of flesh and blood, can search and pick that meridian stasis stagnates, dispelling wind for relieving itching, dredge the meridian passage, and can nourish skin, improve the dry disease of blood, are monarch drug altogether; Ramulus Cinnamomi, Radix Angelicae Sinensis, cattle sunset temperature three-way meridian, blood circulation promoting and blood stasis dispelling, eliminating toxin, be off the beaten track, be to be ministerial drug; Assistant is with the hemostasis of Radix Paeoniae Rubra, Cortex Moutan removing heat from blood and promoting blood circulation, and Herba Schizonepetae, Radix Saposhnikoviae, Rhizoma Gastrodiae, Fructus Chaenomelis expelling wind and removing dampness are antipruritic, outstanding wonderfully helping insect medicine to remove the spasticity of pathological changes meridians with Rhizoma Gastrodiae, Fructus Chaenomelis, the enhancing drug effect; Make with Pericarpium Citri Reticulatae, Caulis Bambusae In Taenia, Radix Bupleuri, Radix Glycyrrhizae dispersing the stagnated live-QI to relieve the stagnation of QI, relieving QI stagnancy in the stomach,, reach recovery from illness in order to clothes treatment for a long time.Above-mentioned all medicines share, and play altogether that dredge the meridian passage, dispersing the stagnated live-QI to relieve the stagnation of QI, expelling wind and removing dampness are antipruritic, the specially good effect of removing heat from blood and promoting blood circulation toxin expelling, and taking convenience, have no side effect, and this side of more special person for drawing, need not dieting with wine, opens the beginning for the treatment of skin disease medication.
The specific embodiment
Embodiment: with Bombyx Batryticatus 40g (account for 8% of total side amount, down with), Zaocys 35g (7%), Squama Manis 30g (6%), Scorpio 10g (2%), Rhizoma Gastrodiae 30g (6%), Scolopendra 10g (2%), Ramulus Cinnamomi 30g (6%), Radix Angelicae Sinensis 35g (7%), Radix Bupleuri 25g (5%), river cattle sunset 25g (5%), Caulis Bambusae In Taenia 20g (4%), Fructus Chaenomelis 35g (7%), Radix Paeoniae Rubra 25g (5%), Cortex Moutan 25g (5%), Herba Schizonepetae 35g (7%), Radix Saposhnikoviae 35g (7%), Pericarpium Citri Reticulatae 15g (3%), Radix Glycyrrhizae 40g (8%) prescription and be prepared into the honeyed pill that every ball contains crude drug in whole 4.5 grams.
Usage and dosage: three times on the oral one, two balls once, general 10 days is a course of treatment
Observation of curative effect: example surplus the clinical treatment 100, total effective rate reaches 97.2%, cure rate 73.8%, effect is remarkable, is the good medicine of clinical treatment.

Claims (2)

1. psoriatic Chinese patent medicine of treatment, the weight percent content that it is characterized in that constituting each medicine material of this Chinese patent medicine is:
Bombyx Batryticatus 6%~10%; Zaocys 5%~9%;
Squama Manis 4%~8%; Scorpio 1.6%~3%;
Rhizoma Gastrodiae 4%~8%; Scolopendra 1.6%~3%;
Ramulus Cinnamomi 4%~8%; Radix Angelicae Sinensis 5%~9%;
Radix Bupleuri 3%~7%; River cattle sunset 5%~9%;
Caulis Bambusae In Taenia 3%~6%; Fructus Chaenomelis 5%~9%;
Radix Paeoniae Rubra 3%~7%; Cortex Moutan 3%~7%;
Herba Schizonepetae 5%~9%; Radix Saposhnikoviae 5%~9%;
Pericarpium Citri Reticulatae 2%~4%; Radix Glycyrrhizae 6%~10%.
2. the psoriatic Chinese patent medicine of treatment as claimed in claim 1, the weight percent content that it is characterized in that constituting each medicine material of this Chinese patent medicine is: Bombyx Batryticatus 8%, Zaocys 7%, Squama Manis 6%, Scorpio 2%, Rhizoma Gastrodiae 6%, Scolopendra 2%, Ramulus Cinnamomi 6%, Radix Angelicae Sinensis 7%, Radix Bupleuri 5%, river cattle sunset 5%, Caulis Bambusae In Taenia 4%, Fructus Chaenomelis 7%, Radix Paeoniae Rubra 5%, Cortex Moutan 5%, Herba Schizonepetae 7%, Radix Saposhnikoviae 7%, Pericarpium Citri Reticulatae 3%, Radix Glycyrrhizae 8%.
CN2005100429520A 2005-07-18 2005-07-18 Chinese patented medicine for treating psoriasis Expired - Fee Related CN1899528B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2005100429520A CN1899528B (en) 2005-07-18 2005-07-18 Chinese patented medicine for treating psoriasis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2005100429520A CN1899528B (en) 2005-07-18 2005-07-18 Chinese patented medicine for treating psoriasis

Publications (2)

Publication Number Publication Date
CN1899528A CN1899528A (en) 2007-01-24
CN1899528B true CN1899528B (en) 2010-07-28

Family

ID=37655639

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2005100429520A Expired - Fee Related CN1899528B (en) 2005-07-18 2005-07-18 Chinese patented medicine for treating psoriasis

Country Status (1)

Country Link
CN (1) CN1899528B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105267720A (en) * 2014-07-13 2016-01-27 胡培芹 Chinese patent medicine for treating psoriasis

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1333028A (en) * 2000-07-12 2002-01-30 赵树人 External liniment for treating rheumatic arthritis
CN1422646A (en) * 2001-12-03 2003-06-11 吴永忠 Chinese medicinal preparation for treating osteoproliferation and various rheumatalgia

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1333028A (en) * 2000-07-12 2002-01-30 赵树人 External liniment for treating rheumatic arthritis
CN1422646A (en) * 2001-12-03 2003-06-11 吴永忠 Chinese medicinal preparation for treating osteoproliferation and various rheumatalgia

Also Published As

Publication number Publication date
CN1899528A (en) 2007-01-24

Similar Documents

Publication Publication Date Title
CN101596230B (en) Medicinal composition for treating hepatopathy
CN1051237C (en) Meicinal prepn. "Kexianling" for curing epilepsy
CN102688420B (en) Traditional Chinese medicine decoction for treating psoriasis
CN101708237B (en) Medicinal composition used for tonifying qi and invigorating pulse, preparation method thereof and application thereof
CN1087625C (en) Traditional Chinese medicine preparation for treating colitis
CN101537159B (en) Traditional Chinese medicine composition and preparation method and application thereof
CN101375988B (en) Anti-inflammation formulation for treating acute prostatitis and preparation method thereof
CN102416145B (en) Chinese medicinal composition for treating menstrual disorder
CN102657736B (en) Medicament composition for treating rheumatoid arthritis and preparation method of medicament composition
CN102526635B (en) Medicament for treating premenstrual stress syndrome and preparation method thereof
CN1899528B (en) Chinese patented medicine for treating psoriasis
CN103239562B (en) Traditional Kazak medicament composition for treating diabetes mellitus and preparation method of traditional Kazak medicament composition
CN102198207A (en) External washing lotion used for treating gynecological vaginitis and cervicitis
CN102145127A (en) Medicament for treating rheumatoid arthritis and preparation method thereof
CN101698085B (en) Medicine composite for treating early liver fibrosis or early hepatocirrhosis decompensation, preparation method and application
CN1247086A (en) Process for making medical wine for treating rheumatism
CN101057922A (en) Traditional Chinese medicine preparation for treating vitiligo
CN103705846A (en) Traditional Chinese medicine preparation for treating ovarian cyst
CN104116957B (en) Pharmaceutical composition for treating organ fibrosis and preparation method and application thereof
CN102652774A (en) Drug composition for treating leukopenia and hypoimmunity caused by chemoradiotherapy and preparation method and quality detection method
CN1712055A (en) Chinese medicinal preparation (litholytic capsule) for treating urinific calculus
CN103285107A (en) Alcoholic hepatitis treatment Kazakh traditional drug composition and preparation method thereof
CN102488804A (en) Traditional Chinese medicine for treating cirrhosis
CN100342879C (en) Liver fibrosis treating prepn and its process
CN102949684B (en) Medicine formula for treating rheumatoid arthritis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20100728

Termination date: 20160718

CF01 Termination of patent right due to non-payment of annual fee